Χώρα: Κύπρος
Γλώσσα: Ελληνικά
Πηγή: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
SODIUM PYROPHOSPHATE DECAHYDRATE
NATIONAL CENTRE FOR NUCLEAR RESEARCH (0000009483) ANDRZEJA SOLTANA STR. 7, OTWOCK, 05-400
V09GA06
TECHNETIUM (99MTC) STANNOUS AGENT LABELLED CELLS
13.40MG/VIAL
POWDER FOR INJECTION
SODIUM PYROPHOSPHATE DECAHYDRATE (0013472361) 13,4MG
INTRAVENOUS USE
Ειδική άδεια άρθρο 126A
TECHNETIUM (99mTc) STANNOUS AGENT LABELLED CELLS
Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 6 VIALS () 6 VIAL - Εγκεκριμένο - Με Ιατρική Συνταγή
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT POLTECHRBC, 13.40 MG, LYOPHILISATE FOR SOLUTION FOR INJECTION _Stanni pyrophosphatis et technetii (_ _99m_ _Tc) solutio iniectabilis _ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your referring doctor or your nuclear medicine doctor who will supervise the procedure. - If you get any side effects, talk to your nuclear medicine doctor. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET : 1. What PoltechRBC is and what it is used for. 2. What you need to know before PoltechRBC is used. 3. How PoltechRBC is used. 4. Possible side effects. 5. How PoltechRBC is stored. 6. Contents of the pack and other information. 1.WHAT POLTECHRBC IS AND WHAT IT IS USED FOR This medicine is a radiopharmaceutical product for diagnostic use only. PoltechRBC is used for: Blood pool scintigraphy with labelled red blood cells, which is useful for: • scintigraphy to assess: - cardiac ventricles ejection fraction, - regional and global cardiac walls motion. • imaging of perfusion of organs and vascular malformations, • diagnosis and localisation of gastrointestinal bleeding. Assessment of blood volume. Spleen scintigraphy. The use of PoltechRBC does involve exposure to small amounts of radioactivity. Your doctor has considered that the clinical benefit that you will obtain from the procedure with the radiopharmaceutical outweights the risk due to ionising radiation. 2.WHAT YOU NEED TO KNOW BEFORE POLTECHRBC IS USED POLTECHRBC MUST NOT BE USED PoltechRBC must not be used if you are allergic (hypersensitive) to the active substance or any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Inform the nuclear medicine doctor who is supervising the examination in the following cases: - if you are pregnant or believe you may be pregnant, - if you are breast-feeding, - if you are under 18 years old. Διαβάστε το πλήρες έγγραφο